A recent paper by Grutters et al makes the case for early health economic modeling in the development of health technologies. A number of examples of the value of early modeling are given, with analyses being performed at different stages in the development of several non-drug health technologies. This commentary acknowledges the contribution of the paper by Grutters et al and argues for an iterative and integrated approach to early modeling, assessing the cost-effectiveness of the technology, the value of future research and the interaction with the manufacturer’s pricing and revenue expectations
Worldwide, billions of dollars are invested in medical product development\ud and there is an increa...
Contains fulltext : 229282.pdf (Publisher’s version ) (Open Access)Early health te...
New health technologies require development and evaluation ahead of being incorporated into the pati...
Early economic modelling has long been recommended to aid research and development (R&D)...
Background: To assess whether early health economic modeling helps to distinguish those healthcare i...
This commentary considers the positive and negative consequences of early economic modelling and exp...
Grutters et al recently investigated the role of early health economic modelling of health technolog...
Grutters et al recently investigated the role of early health economic modelling of hea...
In a review recently published in this journal, Grutters et al outline the scope and impact of their...
Grutters et al show that economic assessments can inform the development of new health ...
In a review recently published in this journal, Grutters et al outline the scope and impact of their...
In this commentary, we discuss early stage assessments of innovative medical technologies...
With their article, Grutters et al raise an important question: What do successful health technology...
The current system of health technology development is characterised by multiple misalignments. The ...
Lehoux et al provide a highly valid contribution in conceptualizing value in value propositions for ...
Worldwide, billions of dollars are invested in medical product development\ud and there is an increa...
Contains fulltext : 229282.pdf (Publisher’s version ) (Open Access)Early health te...
New health technologies require development and evaluation ahead of being incorporated into the pati...
Early economic modelling has long been recommended to aid research and development (R&D)...
Background: To assess whether early health economic modeling helps to distinguish those healthcare i...
This commentary considers the positive and negative consequences of early economic modelling and exp...
Grutters et al recently investigated the role of early health economic modelling of health technolog...
Grutters et al recently investigated the role of early health economic modelling of hea...
In a review recently published in this journal, Grutters et al outline the scope and impact of their...
Grutters et al show that economic assessments can inform the development of new health ...
In a review recently published in this journal, Grutters et al outline the scope and impact of their...
In this commentary, we discuss early stage assessments of innovative medical technologies...
With their article, Grutters et al raise an important question: What do successful health technology...
The current system of health technology development is characterised by multiple misalignments. The ...
Lehoux et al provide a highly valid contribution in conceptualizing value in value propositions for ...
Worldwide, billions of dollars are invested in medical product development\ud and there is an increa...
Contains fulltext : 229282.pdf (Publisher’s version ) (Open Access)Early health te...
New health technologies require development and evaluation ahead of being incorporated into the pati...